Pasireotide, sold under the brand name Signifor, is an orphan drug approved in the United States and the European Union for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy
Taking L-carnitine before exercise can help reduce muscle soreness while enhancing endurance and energy levels
Intranasal silk fibroin/crocetin nanoparticles can cross the BBB, improve brain targeting, and harness their antioxidant potential (Perteghella et al., 2021), offering promise in AD therapy
Keep vials protected from light in their original carton
Melcangi and Bortolato have received research grants from the Post-Finasteride Syndrome Foundation
CP: Conceptualization, Formal analysis, Supervision, Writing original draft, Writing review & editing